FDA MedWatch Safety AlertsUnited States3 September 2026
B. Braun Medical Inc. Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container Due to the Presence of Particulate Matter
This is an official announcement record
Firsthand records what FDA MedWatch Safety Alerts announced and links to the original. The wording below is theirs, not ours.
FOR IMMEDIATE RELEASE – September 3, 2026– Bethlehem, PA, B. Braun Medical Inc (B. Braun) is voluntarily recalling three (3) lots of 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container, to the hospital/healthcare facility/user level due to presence of particulate matter identified
Read the official announcement
Opens www.fda.gov
More from FDA MedWatch Safety Alerts
- Greenwich Rx Issues Voluntary Nationwide Recall of Compounded Glutathione Due to Elevated Endotoxin Levels1 October 2026
- Angiographic Catheter Recall: Boston Scientific Removes Imager II Angiographic Catheters25 September 2026
- Heart Pump Controller Recall: Abiomed Removes Automated Impella Controllers24 September 2026
- Convenience Kit Correction: Becton Dickinson Issues Correction for Kits and Procedure Trays Containing Recalled Sodium Chloride Ampules24 September 2026
- Early Alert: Ventilator Issue from React Health23 September 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program — especially if you are pregnant, nursing, taking medication, or managing a health condition.